Your funeral buddy. They can have the best data in the world but if they run out of cash they will fold. Genentech can buy the drug from the receivers. Everybody wins. Except JG and except the retails but Big Pharma wins what a surprise.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)